Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic......READ MORE
Noncovalent BTK inhibitors (eg, pirtobrutinib) have generated promising data in the later-line treatment of chronic lymphocytic leukemia (CLL). Piv......READ MORE
patient care perspectives by Kenneth C. Anderson, MD
Chimeric antigen receptor (CAR) T-cell therapy has shown impressive responses in patients with heavily pretreated multiple myeloma. An open and tra......READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
Chronic graft-versus-host disease (cGVHD) may impact patient well-being in ways that are challenging to observe, and patient experiences vary widel......READ MORE
expert roundtables by Kenneth C. Anderson, MD; Sagar Lonial, MD, FACP; and S. Vincent Rajkumar, MD
While the ability to treat patients with highly refractory multiple myeloma is promising, a great need remains for novel agents and additional ther......READ MORE
patient care perspectives by Sara M. Tolaney, MD, MPH
Individualizing therapy for patients with human epidermal growth factor receptor 2–positive (HER2+) breast cancer currently involves the considerat......READ MORE